Medicus Pharma Ltd. (NASDAQ: MDCX) announced the enrollment of the first patient in a Phase 2 clinical study in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE